Impact of the COVID-19 pandemic on the Smart Inhalers Market

Smart inhalers are compact inhaler devices used to deliver multiple inhalation drugs such as anticholinergics, glucocorticoids, and beta antagonists. According to CDC data in 2016, about 26.5 million people in the United States had asthma and about 1.7 million people during the emergency room visit had asthma as the primary diagnosis. Smart inhalers include sensors connected to the inhaler device, so you can maintain inhaler records to increase patient compliance and monitoring.

The smart inhaler market size was estimated at $34 million in 2018, and increased to $1,406 million by 2026 during the forecast period, reaching a CAGR of 58.4% from 2019 to 2026. The inhaler sector accounted for more than half. Total market share in 2018

Click here to access the free sample report: https://www.alliedmarketresearch.com/request-sample/1715

The main factor resulting from the increase in smart inhalers is increased prevalence of COPD and asthma. Among them, COPD is expected to be the third leading cause of death worldwide by 2030. Technological advances, along with better treatment options, ease of use and increase are other key factors driving this market in patient compliance with smart inhalers. However, the lack of reimbursement for smart inhalers and the limited availability of smart inhalers in developing regions is expected to curb the growth of the global smart inhaler market.

Currently, Adherium is the most approved product offered by Adherium and is a major player in this market. However, smart inhalers are a profitable market and there is increasing acquisition and collaboration between pharmaceutical companies and smart inhalers manufacturers.

know more: https://www.alliedmarketresearch.com/smart-inhalers-market

Based on distribution channels, the market is divided into hospitals, retail pharmacies and online pharmacies. The retail pharmacy segment is the highest contributor to the distribution channel segment. However, the online pharmacy sector is the most growing sector, and manufacturing companies offer smart inhalers directly at the door, which is expected to propagate to higher growth rates during the forecast period due to preferences for other pharmacies.

This report provides a comprehensive analysis of the key players operating in this market. These include Adherium, Astrazeneca plc., Glaxo Smith Kline, Cohero Health Inc., Novartis International AG, ResMed Inc., Opko Health Inc., Boehringer Ingelheim Group and Vectura Group plc.

Purchase Inquiries: https://www.alliedmarketresearch.com/purchase-enquiry/1715

The main results of the smart inhaler market research:
• North America accounted for more than a third of the global smart inhaler market in 2018.
• Inhaler segments make the most contribution in the product segment.
• Online pharmacies in the distribution channel sector are expected to have the highest CAGR during the forecast period.
• Hospitals in the distribution channel sector accounted for three-quarters of the market share in 2018.
• Sprayers in the by-products sector are expected to grow at the highest rate during the forecast period.
• Asthma by category of display was the largest growth in the market.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.